Market Tracker

02/23 1:27pm ET

Array Biopharma Inc (NASDAQ:ARRY)

10.40
BATS BZX Real-Time Price
As of 1:25pm ET
 -0.345 / -3.21%
Today’s Change
2.44
Today|||52-Week Range
13.40
+18.26%
Year-to-Date
How High Can Array BioPharma Inc. Stock Go?
Feb 21 / MotleyFool.com - Paid Partner Content
Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017?
Feb 10 / MotleyFool.com - Paid Partner Content
Want to Get In on Biotech? Check Out These 3 Stocks
Feb 15 / MotleyFool.com - Paid Partner Content
Here's Why Array Biopharma Inc Stock Is Climbing Again Today
Feb 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.74
Today’s open10.77
Day’s range10.31 - 10.83
Volume84,293
Average volume (3 months)4,164,607
Market cap$1.8B
Dividend yield--
Data as of 1:25pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-9.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.05+0.16%
CBMCambrex Corp+0.45+0.82%
PRTAProthena Corporation...-0.96-1.75%
SRPTSarepta Therapeutics...+0.14+0.46%
Data as of 1:26pm ET, 02/23/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts